From genetics to bariatric surgery and soda taxes: Using all the tools to curb the rising tide of obesity

1. NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet. 2017;390 : 2627–2642 https://doi.org/10.1016/S0140-6736(17)32129-3

2. Overweight and obesity [Internet]. WHO. c2020 -⁠ [cited 2020 Jul 1] Available from: http://www.who.int/gho/ncd/risk_factors/overweight/en/.

3. AMA Classifies Obesity as a Disease. In: Obes. Med. Assoc; c2020 [cited 2020 Jul 1]. Available from: https://obesitymedicine.org/ama-adopts-policy-recognize-obesity-disease/.

4. About UK Biobank [Internet]. UK Biobank; c2019. Available from: https://www.ukbiobank.ac.uk/about-biobank-uk/

5. Dashti HS, Hivert M-F, Levy DE, McCurley JL, Saxena R, Thorndike AN. Polygenic risk score for obesity and the quality, quantity, and timing of workplace food purchases: A secondary analysis from the ChooseWell 365 randomised trial. PLoS Med. 2020;17(7):e1003219. https://doi.org/10.1371/journal.pmed.1003219

6. Chami N, Preuss M, Walker RW, Moscati A, Loos RJF. The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population. PLoS Med. 2020;17(7): e1003196. https://doi.org/10.1371/journal.pmed.1003196

7. Jiang G, Luk AO, Tam CHT, Lau ES, Ozaki R, Chow EYK, et al. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank. PLoS Med. 2020;17(7): e1003209. https://doi.org/10.1371/journal.pmed.1003209

8. Dai H, Alsalhe TA, Chalghaf N, Riccò M, Bragazzi NL, Wu J. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: An analysis of the Global Burden of Disease Study. PLoS Med. 2020;17(7): e1003198. https://doi.org/10.1371/journal.pmed.1003198

9. Salgado MV, Penko J, Fernandez A, Konfino J, Coxson PG, Bibbins-Domingo K, et al. Projected impact of a reduction in sugar-sweetened beverage consumption on diabetes and cardiovascular disease in Argentina: A modeling study. PLoS Med. 2020;17(7): e1003224. https://doi.org/10.1371/journal.pmed.1003224

10. Reyes M, Smith Taillie L, Popkin B, Kanter R, Vandevijvere S, Corvalán C. Changes in the amount of nutrient of packaged foods and beverages after the initial implementation of the Chilean Law of Food Labelling and Advertising: A nonexperimental prospective study. PLoS Med. 2020;17(7): e1003220. https://doi.org/10.1371/journal.pmed.1003220

11. Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Med. 2020;17(7): e1003206. https://doi.org/10.1371/journal.pmed.1003206

12. Caro JC, Corvalán C, Reyes M, Silva A, Popkin B, Taillie LS. Chile’s 2014 sugar-sweetened beverage tax and changes in prices and purchases of sugar-sweetened beverages: An observational study in an urban environment. PLoS Med. 2018;15(7): e1002597. doi: 10.1371/journal.pmed.1002597 29969444

13. Goiana-da-Silva F, Severo M, Cruz e Silva D, Gregório MJ, Allen LN, Muc M, et al. Projected impact of the Portuguese sugar-sweetened beverage tax on obesity incidence across different age groups: A modelling study. PLoS Med. 2020;17(3): e1003036. doi: 10.1371/journal.pmed.1003036 32163412

14. Scarborough P, Adhikari V, Harrington RA, Elhussein A, Briggs A, Rayner M, et al. Impact of the announcement and implementation of the UK Soft Drinks Industry Levy on sugar content, price, product size and number of available soft drinks in the UK, 2015–19: A controlled interrupted time series analysis. PLoS Med. 2020;17(2): e1003025. doi: 10.1371/journal.pmed.1003025 32045418